Leiomyosarcoma of the Prostate after Prior Adenocarcinoma: A Rare and Aggressive Malignancy on FDG PET/CT
Indian Journal of Nuclear Medicine · 27.04.2026 · 41 · 364-366
DOI: 10.25259/ijnm_2_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 27.04.2026. Verfasst von Kevser Oksuzoglu und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
The prostatic sarcomas are exceedingly rare, constituting less than 0.1% of all primary prostate neoplasms. Although the importance of Ga-68 prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in prostate adenocarcinoma is well established, it is not useful in prostate sarcomas. Herein, we present fluorodeoxyglucose ( 18 F-FDG) PET/CT findings of an 81-year-old man with a prostatic mass, which confirmed the diagnosis of leiomyosarcoma.
Zitieren
APA
Oksuzoglu, K., Perktas, L., Önner, H., & Yılmaz, F. (2026). Leiomyosarcoma of the Prostate after Prior Adenocarcinoma: A Rare and Aggressive Malignancy on FDG PET/CT. Indian Journal of Nuclear Medicine, 41, 364-366. https://doi.org/10.25259/ijnm_2_2026
Vancouver
Oksuzoglu K, Perktas L, Önner H, Yılmaz F. Leiomyosarcoma of the Prostate after Prior Adenocarcinoma: A Rare and Aggressive Malignancy on FDG PET/CT. Indian Journal of Nuclear Medicine. 2026;41:364-366. doi:10.25259/ijnm_2_2026
BibTeX
@article{Oksuzoglu2026,
author = {Oksuzoglu, Kevser and Perktas, Lutfu and Önner, Hasan and Yılmaz, Farise},
title = {Leiomyosarcoma of the Prostate after Prior Adenocarcinoma: A Rare and Aggressive Malignancy on FDG PET/CT},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {41},
pages = {364--366},
doi = {10.25259/ijnm_2_2026}
}
EUVIMED